13FPulse
中
RP

RPRX Royalty Pharma plc

2026Q2 · CUSIP G7709Q104 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
634
Institutions that reported holding it to the SEC
Net increase in holders
+48
Last quarter 586 → now 634
How unusual is that
Top 10%
Stronger buying than 94% of US stocks
What the filings say, in one paragraph

634 funds held RPRX at the end of 2026Q2, up 48 from the quarter before. That is stronger buying than 94.2% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $2.5B(YoY +10.0%), the P/E is 33.7x, return on equity is 8.3%. RPRX has had 14 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2020Q3: holders=130 2020Q4: holders=196 2021Q1: holders=209 2021Q2: holders=231 2021Q3: holders=226 2021Q4: holders=264 2022Q1: holders=275 2022Q2: holders=282 2022Q3: holders=316 2022Q4: holders=334 2023Q1: holders=334 2023Q2: holders=326 2023Q3: holders=312 2023Q4: holders=363 2024Q1: holders=379 2024Q2: holders=377 2024Q3: holders=392 2024Q4: holders=415 2025Q1: holders=443 2025Q2: holders=456 2025Q3: holders=485 2025Q4: holders=536 2026Q1: holders=586 2026Q2: holders=634 -66 -33 +0 +33 +66 117392666 20Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 14 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 10% — —
2026Q1 Top 5% — —
2025Q4 Top 10% — —
2025Q3 Top 20% — —
2025Q1 Top 10% — —
2024Q1 Top 20% — —
2023Q4 Top 10% — —
2022Q3 Top 5% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
257
Change in large funds
+21
Total value they hold
$20.5B
Funds buying for the first time
107
Funds that sold out entirely
59
Price change that quarter
—
Funds holding puts (bearish)
4
Funds holding calls (bullish)
6

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
33.7
EPS (TTM)
$1.87
EPS YoY
-18.3%
Revenue (TTM)
$2.5B
Revenue YoY
+10.0%
Net margin
32.0%
ROE
8.3%
Debt ratio
50.6%
FCF (TTM)
—
Dividend (TTM)
$0.91
Quarterly Revenue & EPS
2021-09-30: EPS 0.24 2021-12-31: EPS -0.01 2022-03-31: EPS 0.12 2022-06-30: EPS 0.70 2022-09-30: EPS 0.32 2022-12-31: EPS -1.04 2023-03-31: EPS 0.76 2023-06-30: EPS 0.50 2023-09-30: EPS 0.16 2023-12-31: EPS 1.11 2024-03-31: EPS 0.01 2024-06-30: EPS 0.23 2024-09-30: EPS 1.21 2024-12-31: EPS 0.46 2025-03-31: EPS 0.55 2025-06-30: EPS 0.07 2025-09-30: EPS 0.67 2025-12-31: EPS 0.49 2026-03-31: EPS 0.67 2026-06-30: EPS 0.04 0M 342M 684M $M -1.14 0.09 1.33 2019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 25 9 184 359 20222023202420252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.